Blog The Medical Research Act Confidential reimbursement amounts in Germany only attractive for individual cases more
Blog The Medical Research Act Exemption from AMNOG pricing guardrails if relevant proportion of clinical trials are conducted in Germany more
Blog National strategy for gene and cell therapies (GCT) handed over Starting signal for a solution-orientated concept for Germany more
Blog EU HTA: Successfully navigating the methodological framework New methodological guidance documents more